Stifel Raises Valeant PT As Co. Continues To Execute Global Expansion Strategy
April 30, 2015 at 09:54 AM EDT
Stifel on Thursday issued a company report on Valeant Pharmaceuticals Intl Inc. (NYSE: VRX) after the company reported revenues of $2.19 ...
